Read More Pharma Industry News How Persevere Therapeutics plans to reposition misetionamide in a crowded ovarian cancer pipeline Persevere Therapeutics launches misetionamide ovarian cancer trial. Discover how its strategy could reshape treatment competition. bySoujanya RaviMarch 6, 2026